Bioequivalence and Bioavailability Forum

Main page Policy Latest Posts Abbreviations

IV: Liposome encapsuled drug, pegylated biologic? [Off Topic]

posted by Darborn – Taiwan, 2024-08-06 07:15 (290 d 02:11 ago) – Posting: # 24141
Views: 2,442

Hi Helmut,

It is actual a FDC which the elimination of one drug is interupted by another. So the overall exposure is increased to reduce the administration times per day.

Complete thread:

A boring question about bioavailability? Darborn 2024-08-01 09:05 [Off Topic]
- ƒ of IV = 1 by definition, but… Helmut 2024-08-01 12:05
  - ƒ of IV = 1 by definition, but… Darborn 2024-08-01 12:36
    - IV: Different half-lives? Helmut 2024-08-01 13:43
      - IV: Different half-lives? Darborn 2024-08-02 02:39
        
        IV: Liposome encapsuled drug, pegylated biologic? Helmut 2024-08-02 07:52
        
        IV: Liposome encapsuled drug, pegylated biologic?Darborn 2024-08-06 05:15

Admin contact
23,424 posts in 4,927 threads, 1,679 registered users;
44 visitors (0 registered, 44 guests [including 20 identified bots]).
Forum time: 09:27 CEST (Europe/Vienna)

Pharmacokinetics may be simply defined as
what the body does to the drug,
as opposed to pharmacodynamics, which may be defined as
what the drug does to the body. Leslie Z. Benet

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz